Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 100

1.

Improved foot-and-mouth disease vaccine, O TWN-R, protects pigs against SEA topotype virus occurred in South Korea.

Choi JH, Ko MK, Shin SH, You SH, Jo HE, Jo H, Lee MJ, Kim SM, Lee JS, Kim B, Park JH.

Vet Microbiol. 2019 Sep;236:108374. doi: 10.1016/j.vetmic.2019.07.026. Epub 2019 Jul 25.

PMID:
31500734
2.

New foot-and-mouth disease vaccine, O JC-R, induce complete protection to pigs against SEA topotype viruses occurred in South Korea, 2014-2015.

Jo HE, Ko MK, Choi JH, Shin SH, Jo H, You SH, Lee MJ, Kim SM, Kim B, Park JH.

J Vet Sci. 2019 Jul;20(4):e42. doi: 10.4142/jvs.2019.20.e42.

3.

Evaluation of a genetically modified foot-and-mouth disease virus vaccine candidate generated by reverse genetics.

Li P, Bai X, Sun P, Li D, Lu Z, Cao Y, Fu Y, Bao H, Chen Y, Xie B, Liu Z.

BMC Vet Res. 2012 May 16;8:57. doi: 10.1186/1746-6148-8-57.

4.

Selection of vaccine strains for serotype O foot-and-mouth disease viruses (2007-2012) circulating in Southeast Asia, East Asia and Far East.

Mahapatra M, Upadhyaya S, Aviso S, Babu A, Hutchings G, Parida S.

Vaccine. 2017 Dec 18;35(51):7147-7153. doi: 10.1016/j.vaccine.2017.10.099. Epub 2017 Nov 20.

5.

Evaluation of cross-protection against three topotypes of serotype O foot-and-mouth disease virus in pigs vaccinated with multi-epitope protein vaccine incorporated with poly(I:C).

Cao Y, Lu Z, Li D, Fan P, Sun P, Bao H, Fu Y, Li P, Bai X, Chen Y, Xie B, Liu Z.

Vet Microbiol. 2014 Jan 31;168(2-4):294-301. doi: 10.1016/j.vetmic.2013.11.023. Epub 2013 Nov 28.

PMID:
24345411
6.

Efficacy of a high quality O1/Campos foot-and-mouth disease vaccine upon challenge with a heterologous Korean O Mya98 lineage virus in pigs.

Galdo Novo S, Malirat V, Maradei ED, Pedemonte AR, Espinoza AM, Smitsaart E, Lee KN, Park JH, Bergmann IE.

Vaccine. 2018 Mar 14;36(12):1570-1576. doi: 10.1016/j.vaccine.2018.02.015. Epub 2018 Feb 19.

PMID:
29472132
7.

Protection to homologous and heterologous challenge in pigs immunized with vaccine against foot-and-mouth disease type O caused an epidemic in East Asia during 2010/2011.

Park JN, Lee SY, Chu JQ, Lee YJ, Kim RH, Lee KN, Kim SM, Tark DS, Kim B, Park JH.

Vaccine. 2014 Apr 1;32(16):1882-9. doi: 10.1016/j.vaccine.2014.01.067. Epub 2014 Feb 10.

PMID:
24525017
8.

Chimeric vaccine strain of type O foot-and-mouth disease elicits a strong immune response in pigs against ME-SA and SEA topotypes.

Ko MK, Jo HE, Choi JH, You SH, Shin SH, Jo H, Lee MJ, Kim SM, Kim B, Park JH.

Vet Microbiol. 2019 Feb;229:124-129. doi: 10.1016/j.vetmic.2018.12.023. Epub 2018 Dec 26.

PMID:
30642587
9.

Cross-protective efficacy of the O1 Manisa + O 3039 bivalent vaccine and the O 3039 monovalent vaccine against heterologous challenge with FMDV O/Jincheon/SKR/2014 in pig.

Kim T, Hong JK, Oem JK, Lee KN, Lee HS, Kim YJ, Ryoo S, Ko YJ, Park JH, Choi J, Lee SH, Jo HJ, Lee MH, Kim B, Kim J.

Vaccine. 2019 Mar 14;37(12):1702-1709. doi: 10.1016/j.vaccine.2018.11.080. Epub 2019 Feb 1.

PMID:
30712811
10.

Protective effects of high-potency FMDV O1 Manisa monovalent vaccine in cattle challenged with FMDV O/SKR/2010 at 7 or 4 days post vaccination.

Horsington J, Perez CB, Maradei E, Novo SG, Gonzales JL, Singanallur NB, Bonastre P, Vosloo W.

Vaccine. 2017 Sep 12;35(38):5179-5185. doi: 10.1016/j.vaccine.2017.07.102. Epub 2017 Aug 5.

PMID:
28789849
11.

Cross-protective efficacy of engineering serotype A foot-and-mouth disease virus vaccine against the two pandemic strains in swine.

Zheng H, Lian K, Yang F, Jin Y, Zhu Z, Guo J, Cao W, Liu H, He J, Zhang K, Li D, Liu X.

Vaccine. 2015 Oct 26;33(43):5772-5778. doi: 10.1016/j.vaccine.2015.09.055. Epub 2015 Oct 1.

PMID:
26431990
12.

Genetic and antigenic characterization of serotype O FMD viruses from East Africa for the selection of suitable vaccine strain.

Lloyd-Jones K, Mahapatra M, Upadhyaya S, Paton DJ, Babu A, Hutchings G, Parida S.

Vaccine. 2017 Dec 14;35(49 Pt B):6842-6849. doi: 10.1016/j.vaccine.2017.10.040.

13.

Heterogeneity and genetic variations of serotypes O and Asia 1 foot-and-mouth disease viruses isolated in Vietnam.

Le VP, Nguyen T, Park JH, Kim SM, Ko YJ, Lee HS, Nguyen VC, Mai TD, Do TH, Cho IS, Lee KN.

Vet Microbiol. 2010 Oct 26;145(3-4):220-9. doi: 10.1016/j.vetmic.2010.04.005. Epub 2010 Apr 18.

PMID:
20478669
14.

Foot-and-mouth disease outbreaks in Egypt during 2013-2014: Molecular characterization of serotypes A, O, and SAT2.

Diab E, Bazid AI, Fawzy M, El-Ashmawy WR, Fayed AA, El-Sayed MM.

Vet World. 2019;12(2):190-197. doi: 10.14202/vetworld.2019.190-197. Epub 2019 Feb 5.

15.
16.

Emergence of an exotic strain of serotype O foot-and-mouth disease virus O/ME-SA/Ind-2001d in South-East Asia in 2015.

Qiu Y, Abila R, Rodtian P, King DP, Knowles NJ, Ngo LT, Le VT, Khounsy S, Bounma P, Lwin S, Verin BC, Widders P.

Transbound Emerg Dis. 2018 Feb;65(1):e104-e112. doi: 10.1111/tbed.12687. Epub 2017 Aug 30.

PMID:
28856846
17.

Early protection in sheep against intratypic heterologous challenge with serotype O foot-and-mouth disease virus using high-potency, emergency vaccine.

Horsington J, Zhang Z, Bittner H, Hole K, Singanallur NB, Alexandersen S, Vosloo W.

Vaccine. 2015 Jan 9;33(3):422-9. doi: 10.1016/j.vaccine.2014.11.043. Epub 2014 Dec 3.

PMID:
25483241
18.

[Construction of a full-length infectious cDNA clone of inter-genotypic chimeric foot-and-mouth disease virus].

Li P, Bai X, Lu Z, Sun P, Qi G, Han C, Liu Z.

Wei Sheng Wu Xue Bao. 2012 Jan;52(1):114-9. Chinese.

PMID:
22489468
19.

Induction of protective immunity in swine by immunization with live attenuated recombinant pseudorabies virus expressing the capsid precursor encoding regions of foot-and-mouth disease virus.

Li X, Liu R, Tang H, Jin M, Chen H, Qian P.

Vaccine. 2008 May 23;26(22):2714-22. doi: 10.1016/j.vaccine.2008.03.020. Epub 2008 Apr 1.

PMID:
18436351
20.

Versatility of the adenovirus-vectored foot-and-mouth disease vaccine platform across multiple foot-and-mouth disease virus serotypes and topotypes using a vaccine dose representative of the AdtA24 conditionally licensed vaccine.

Barrera J, Brake DA, Schutta C, Ettyreddy D, Kamicker BJ, Rasmussen MV, Bravo de Rueda C, Zurita M, Pisano M, Hurtle W, Brough DE, Butman BT, Harper BG, Neilan JG.

Vaccine. 2018 Nov 19;36(48):7345-7352. doi: 10.1016/j.vaccine.2018.10.031. Epub 2018 Oct 13.

Supplemental Content

Support Center